Skip to main content
Premium Trial:

Request an Annual Quote

Upstate to License RheoGene s Gene Regulation Technology

NEW YORK, April 29 (GenomeWeb News) - Rheogene, of Norristown, Pa., said today that it has granted a nonexclusive license to Upstate USA, of Charlottesville, Va., to develop research test kits based on RheoGene's inducible gene regulation system.


Under the terms of the agreement, Upstate will use RheoGene's Rheoswitch system in combination with Upstate's RNAi and antibody research kits. Upstate also obtains a nonexclusive license to RheoGene's RheoPlex multiple gene regulation technology, the company said.


Financial terms of the deal were not provided.

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.